Short Against Long Antibiotic Therapy for Infected Orthopedic Sites

PHASE3CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Orthopedic Devices Associated With MisadventuresInfection, Surgical SiteAntibiotic Side Effect
Interventions
DRUG

Antibiotic

"The investigators will perform two concomitant RCTs, depending on the presence of infected osteosynthesis material at enrolment:~\- SALATIO 1. Infected implant not removed (or new material inserted): Randomization 6 vs. 12 weeks (+/- 5 days) of total antibiotic therapy counted since the first debridement for infection. Early switch to oral targeted therapy.~\- SALATIO 2. Infected implant without residual material (definitive removal or within the interval of a two-stage exchange): Randomization 3 vs. 6 weeks (+/- 5 days) of total antibiotic therapy counted since the first debridement for infection. Early switch to oral targeted therapy."

Trial Locations (1)

8008

Balgrist University Hospital, Zurich

All Listed Sponsors
lead

Balgrist University Hospital

OTHER